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Introduction
Within an infected cell, viral nucleic acid, be it RNA or DNA, 
is relatively cosseted by cellular membranes and a protective 
cytosolic environment, but the cell-free stage that viral genomes 
must transit to access new host cells is fraught with danger.   
Viruses mitigate against these risks by packaging their nucleic 
acid into particles protected by a membrane and/or protein shell. 
This packaging poses a thermodynamic dilemma for a virus: 
particles must be resilient enough to protect the genome from 
environmental and/or immunological insults but also appropri-
ately labile to ensure the contents are released when encountering 
suitable target cells. Thus, viruses are constructed as metastable 
molecular assemblages that can be unlocked during entry by 
specific  molecular  and/or  cellular  environmental  cues,  with 
minimal energetic input (Marsh and Helenius, 2006). Receptors 
are key to the unlocking process, either directly triggering the 
molecular changes that lead to fusion/penetration or by guiding 
virions to specific cellular sites where environmental cues trig-
ger fusion/penetration and subsequent infection. Thus, the un-
locking process is usually directly coupled to the mechanisms 
through which viral genomes are transferred across a limiting 
cellular membrane (usually the plasma membrane or endosome 
membrane), the principal barrier to infection.
In this review, we discuss how events at the cell surface deter-
mine viral entry pathways and, using several different examples, 
examine some of the strategies viruses use to overcome cellular bar-
riers to infection (Fig. 1). Receptor-mediated signaling will emerge 
throughout the review as an important component of virus entry 
that can operate at multiple stages, as will insights into the variations 
that viruses have developed on the principle themes for entry.
Virus receptors
Initial encounters between a virus and a host cell are mediated   
through viral surface components, either membrane glycopro-
teins or sites on a viral capsid (Marsh and Helenius, 2006), bind-
ing to glycolipid and/or glycoprotein attachment factors, such   
as  heparan  sulfate  proteoglycans,  on  the  target  cell  surface   
(de Haan et al., 2005; Vlasak et al., 2005). These first interactions,   
which may lack specificity, are often electrostatic and serve pri-
marily to give a virus an initial catch-hold from which it can 
then recruit specific receptors that drive the reactions leading 
to entry. The receptors are cell surface molecules that provide 
functions essential for productive infection. In simple situations,   
receptors can efficiently target viruses for endocytosis (Fig. 1 A); 
alternatively, receptors may be used to activate specific signal-
ing pathways that facilitate entry, or they may directly drive 
fusion/penetration events at the surface of a target cell or within 
endocytic compartments by inducing conformational changes in 
key virus surface structures (Fig. 1). In other cases, the reasons 
underlying the use of specific receptors are more obscure, and a 
full appreciation will probably require better understanding of 
the mode of entry of the virus into the hosts, the architecture of 
target cells within different tissue environments, and the biol-
ogy of the virus within its hosts. The use of specific cell surface 
components  with  restricted  expression  patterns  is  frequently   
responsible for viral tropism, i.e., the ability of a virus to infect 
a limited set of target cells.
A number of the cell surface components exploited by 
viruses have now been identified (Table I). Many viruses use 
The cell imposes multiple barriers to virus entry. However, 
viruses  exploit  fundamental  cellular  processes  to  gain   
entry to cells and deliver their genetic cargo. Virus entry 
pathways are largely defined by the interactions between 
virus  particles  and  their  receptors  at  the  cell  surface. 
These interactions determine the mechanisms of virus at-
tachment, uptake, intracellular trafficking, and, ultimately, 
penetration to the cytosol. Elucidating the complex inter-
play between viruses and their receptors is necessary for 
a full understanding of how these remarkable agents in-
vade their cellular hosts.
Host–pathogen interactions
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fusion (Choe et al., 1996; Deng et al., 1996; Dragic et al., 
1996; Feng et al., 1996; Haim et al., 2011). Engagement of the 
coreceptor drives further Env structural rearrangements that 
culminate in fusion of the viral and host membranes (Fig. 2 B; 
Dragic et al., 1996).
Another intriguing example of a virus requiring multiple 
cell surface components for entry is hepatitis C virus (HCV). 
Aside  from  attachment  factors  that  include  heparan  sulfate 
and L-SIGN (Barth et al., 2003; Gardner et al., 2003; Pöhlmann   
et al., 2003), the HCV envelope glycoprotein E2 interacts di-
rectly with two receptors: the tetraspanin CD81 that is thought 
to be involved in membrane microdomain architecture (Pileri 
et al., 1998) and SR-B1 that binds several lipoproteins, including 
high-density lipoprotein, low-density lipoprotein, and very low-
density lipoprotein (Scarselli et al., 2002). In addition to these 
key components, the minimal HCV entry complex requires the   
tight junction components claudin-1 and occludin. Thus, co-
expression of four proteins—CD81, SR-B1, claudin-1, and   
occludin—is required to confer permissivity for HCV entry 
(Fig. 2 C; Evans et al., 2007; Liu et al., 2009; Ploss et al., 2009; 
Dorner et al., 2011). There is limited evidence for a direct inter-
action between the HCV glycoproteins and claudin-1 or occlu-
din (Evans et al., 2007; Krieger et al., 2010), indicating that   
these molecules may act by regulating the activities of CD81   
and/or SR-B1 rather than binding viruses directly; indeed, 
heterodimers of claudin-1 and CD81 may be necessary for 
single molecular species as receptors, for example CD155 for   
poliovirus (Mendelsohn et al., 1989), the low-density lipo-
protein receptor (LDLR) for human rhinovirus 2 (Fig. 2 A; Hofer   
et al., 1994), and dendritic cell–specific intercellular adhesion 
molecule-3–grabbing nonintegrin (DC-SIGN) for the phlebo-
viruses (a subgroup of bunyaviruses; Lozach et al., 2011b). Alter-
natively, some viruses can use more than one molecular species 
as receptors, each with equivalent roles, for example, angiotensin-
converting enzyme (ACE) or liver-SIGN (L-SIGN) for SARS 
coronavirus (Li et al., 2003; Jeffers et al., 2004) and scaven-
ger receptor-B2 (SR-B2) or P-selectin glycoprotein ligand-1   
(PSGL-1) for enterovirus 71 (Table I; Nishimura et al., 2009; 
Yamayoshi  et  al.,  2009).  However,  other  viruses  exhibit  a 
more  complex  receptor  dependency  that  involves  engage-
ment with at least two distinct plasma membrane components, 
each of which is essential (Fig. 2). Human immunodeficiency 
viruses (HIVs) are the archetype for such a process. After 
adsorption to cell surface attachment factors, the HIV enve-
lope protein (Env, consisting of trimers of gp120/gp41 hetero-
dimers) binds to the primary receptor CD4 (Dalgleish et al., 
1984; Klatzmann et al., 1984). By relieving constraints that 
prevent Env from transitioning to thermodynamically more 
stable conformations, these interactions initiate conforma-
tional  changes  that  facilitate  strain-specific  interactions  of 
gp120 with the coreceptors CCR5 or CXCR4 and allow initial 
structural changes in gp41, the Env component that promotes 
Figure 1.  Virus entry strategies. The cell imposes intrinsic barriers to virus entry including the plasma membrane, actin cortex, and limiting intracellular 
membranes. (A and B) Viruses have evolved various strategies to overcome these barriers, such as receptor-mediated endocytosis followed by pH-dependent/
independent fusion from endocytic compartments (A) or pH-independent fusion at the plasma membrane, coupled with receptor-mediated signaling and 
coordinated disassembly of the actin cortex (B). Enveloped viruses are shown; nonenveloped viruses use similar strategies, although the mechanisms of 
action are different. MVB, multivesicular body.1073 Receptor-mediated virus entry • Grove and Marsh
Krummenacher, 2008; Burckhardt et al., 2011). Simply, the use of   
multiple receptors will increase binding avidity, but, of more 
consequence, the sequential engagement of distinct receptor moi-
eties allows the timing of key events in virus fusion/penetration 
to be tightly coordinated (López and Arias, 2004; Burckhardt   
et al., 2011). Although viruses have the potential to cluster ho-
mogenous or heterogenous receptors, we know relatively little 
of the stoichiometry of receptor engagement. How viruses as-
semble multimeric receptor complexes on the surfaces of cells 
and the impacts that variations in this process have on fusion/
penetration dynamics, sites of entry, and subsequent uncoating 
remain poorly understood. Lateral motion on the cell surface 
or along filopodia has been observed for several viruses and 
may help viruses encounter necessary coreceptors in numbers 
sufficient to generate productive entry events (Lehmann et al., 
2005; Burckhardt and Greber, 2009). Alternatively, it may bring 
viruses to positions of endocytosis or where fusion/penetration 
is more likely to lead to productive infection. High-resolution 
mapping of most cell surface receptors by EM, super-resolution 
light nanoscopy, and live-cell single-molecule tracking remains 
to be performed. In the case of virus receptors, mapping the 
infection (Harris et al., 2008, 2010). HCV requires clathrin-
mediated endocytosis and low endosomal pH for productive in-
fection (Blanchard et al., 2006; Meertens et al., 2006; Tscherne   
et al., 2006). That HCV uses such a complex array of cell surface 
components to achieve this goal suggests that receptor engage-
ment plays a more substantial role in virus entry than just guiding 
virions into clathrin-coated vesicles. Hints that this may be the 
case include the observation that HCV particles associate with 
host lipoproteins that bind both SR-B1 and/or the LDLR and that 
SR-B1 can facilitate the bidirectional transport of cholesterol 
from lipoproteins, raising the possibility that virion-associated 
lipoproteins can locally modify the lipid environment of a host 
cell membrane (Scarselli et al., 2002; Shimizu et al., 2011). 
In addition, HCV entry can be modulated by receptor tyrosine 
kinases (EGF receptor [EGFR] and EphA2), possibly through 
mechanisms that influence CD81 interaction with claudin-1 
(Lupberger et al., 2011).
In  addition  to  HIV  and  HCV,  other  viruses  including   
adenoviruses, rotaviruses, picornaviruses, and herpesviruses 
require  multiple  cell  surface  components  (Table  I;  López 
and Arias, 2004; Coyne and Bergelson, 2006; Heldwein and   
Table I.  Virus receptors used in this study
Virus Family Receptors Reference
Old World arenaviruses Arenaviridae -Dystroglycan Cao et al., 1998
New World arenaviruses Arenaviridae Transferrin receptor Radoshitzky et al., 2007
Norovirus Caliciviridae HBGA Huang et al., 2003; Lindesmith et al., 2003 
Japanese encephalitis virus Flaviviridae Hsp70 Das et al., 2009
Influenza A Orthomyxoviridae Sialic acid Matlin et al., 1981
Henipahvirus Paramyxoviridae Nephrin B2 Negrete et al., 2005
Bunyavirus Phleboviridae DC-SIGN Kaplan et al., 1996
Hepatitis A virus Picornaviridae TIM-1 Lozach et al., 2011b
Poliovirus Picornaviridae CD155 Mendelsohn et al., 1989
Rhinovirus (major group) Picornaviridae ICAM-1 Greve et al., 1989; Staunton et al., 1989
Rhinovirus (minor group) Picornaviridae LDLR Hofer et al., 1994
John Cunningham polyomavirus Polyomaviridae LSTc Neu et al., 2010
SV40 polyomavirus Polyomaviridae GM1 Tsai et al., 2003
Reovirus Reoviridae JAM Barton et al., 2001
Sindbis virus Togaviridae Laminin receptor Wang et al., 1992
SARS coronavirus Coronaviridae ACE 2 or L-SIGN Li et al., 2003; Jeffers et al., 2004
Herpes simplex virus 1/2 Herpesviridae Nectin-1/2 or HVEM Montgomery et al., 1996; Geraghty et al., 1998;  
Krummenacher et al., 1998
Measles virus Paramyxoviridae SLAM or Nectin-4 Tatsuo et al., 2000; Noyce et al., 2011
Enterovirus 71 Picornaviridae PSGL-1 or SR-B2 Nishimura et al., 2009; Yamayoshi et al., 2009
Human T cell leukemia virus 1 Retroviridae GLUT-1 or Neuropilin-1 Manel et al., 2003; Ghez et al., 2006
Adenovirus 2 Adenoviridae CAR and v integrins Wickham et al., 1993; Bergelson et al., 1997; Tomko et al., 1997
Ebola virus Filoviridae TIM-1 and NPC1 Carette et al., 2011; Côté et al., 2011; Kondratowicz et al., 2011
HCV Flaviviridae CD81 and SR-B1 
(claudin-1 and occludin)
Pileri et al., 1998; Scarselli et al., 2002;  
Evans et al., 2007; Ploss et al., 2009
Epstein–Barr virus Herpesviridae CD21 and MHC-II Fingeroth et al., 1984; Li et al., 1997
Coxsackievirus B Picornaviridae DAF and CAR (occludin) Bergelson et al., 1997; Martino et al., 1998; Coyne et al., 2007
Rotavirus Reoviridae Sialic acid and integrins Yolken et al., 1987; Coulson et al., 1997; Guerrero et al., 2000
HIV Retroviridae CD4 and CCR5 or CXCR4 Dalgleish et al., 1984; Klatzman et al., 1984; Choe et al., 1996; 
Deng et al., 1996; Dragic et al., 1996; Feng et al., 1996
Virus particles engage a variety of cell surface molecules to facilitate entry. Some virus particles use single-receptor species; others use alternative molecules, either of 
which is sufficient, whereas other viruses require a specific combination of receptors. Factors in parentheses may not directly interact with virus particles; however, they 
are necessary for virus entry. Examples from each category are given and illustrate the diversity of receptors. The majority of the viruses listed are human pathogens. 
ACE, angiotensin-converting enzyme; DAF, decay-accelerating factor; HBGA, histoblood group antigen; HVEM, herpesvirus entry mediator; JAM, junctional adhesion 
molecule; PSGL-1, P-selectin glycoprotein ligand-1; SLAM, signaling lymphocyte-activation molecule.JCB • VOLUME 195 • NUMBER 7 • 2011   1074
exquisite example of how sequential receptor engagement and   
receptor-induced signaling are coupled to facilitate virion trans-
location and entry. Recent findings indicate that a related pico-
rnavirus, echovirus 11, also undergoes DAF-dependent transport 
to the tight junctions, although a junctional coreceptor has yet 
to be identified (Sobo et al., 2011).
Like coxsackievirus B, hepatitis A virus is a fecal orally 
transmitted picornavirus; however, its principal site of replica-
tion is the liver, and it must therefore have developed mecha-
nisms to cross the gut epithelium. In vitro studies suggest that 
hepatitis A virus–specific IgA facilitates transcytosis of virus   
particles through polarized epithelial cells via the polymeric   
immunoglobulin receptor (Dotzauer et al., 2005). Critically, com-
plexed IgA can subsequently mediate hepatitis A virus entry to 
hepatocytes via asialoglycoprotein receptors (Dotzauer et al., 
2000). Thus, IgA acts as a bridging component for sequential 
receptor-mediated hepatitis A virus transit and infection. This 
process appears to be independent of the standard hepatitis A 
virus receptor T cell immunoglobulin and mucin domain 1 
(TIM-1; Kaplan et al., 1996).
In contrast, adenoviruses exploit both the activities of   
immune sentinel cells and receptor polarity to penetrate the respi-
ratory epithelium. Adenovirus type 2 uses CAR and 3/5 
integrins for productive entry (Wickham et al., 1993; Bergelson 
et al., 1997; Tomko et al., 1997). As with CAR, 3 and 5 
are located on the basolateral membrane of polarized respira-
tory epithelial cells, and intact epithelial monolayers are resis-
tant to adenovirus type 2 infection from the apical side. Uptake 
of adenovirus type 2 into macrophages associated with the api-
cal surface of the epithelium induces the secretion of cytokines, 
in particular, CXCL8 (IL-8). In response to CXCL8, receptors 
expressed on respiratory epithelial cells (CXCR1/2) induce re-
distribution of both 3 and CAR to the apical surface, where 
they mediate virus entry (Lütschg et al., 2011). Not only do 
these examples illustrate the sophisticated ways in which some 
viruses sequentially exploit distinct cell surface moieties and 
receptor-signaling activities to successfully mediate infection 
or overcome the barrier function of epithelia, but they also dem-
onstrate how analyzing virus entry in experimental systems that 
normal distributions of receptor components and how these 
distributions are modulated by physiological or viral ligands is 
likely to provide key insights to how receptor engagement facili-
tates virus entry and may suggest novel strategies for abrogating 
these events.
Exploiting receptors to cross  
epithelial barriers
Many mammalian viruses initially gain access to their hosts 
by crossing epithelial barriers in the respiratory, digestive, or 
reproductive tracts, either with or without infection of the epi-
thelial cells themselves. Although these epithelial tissues act as 
barriers between body cavities and underlying tissues, viruses 
have become adept at finding ways across. Some viruses exploit 
cells of the immune system, such as macrophages and dendritic 
cells, which have innate capacities to cross or extend processes 
across epithelia, as “Trojan horses” to penetrate the epithelial 
barrier  (Shannon-Lowe  et  al.,  2006;  Stamataki  et  al.,  2009; 
Lemon et al., 2011). Others have developed remarkable capaci-
ties to exploit epithelial cell surface proteins. The entry of cox-
sackievirus B provides a striking example. This virus infects its   
human hosts through the epithelial lining of the gut. For infec-
tion of polarized epithelial (Caco-2) cells in culture, coxsackie-
virus B requires the coxsackievirus and adenovirus receptor 
(CAR), which is located on the basolateral surface and within 
tight junctions and is inaccessible to apically delivered viruses 
(Cohen et al., 2001). The virions initially bind to an apically 
expressed glycosylphosphatidylinositol-linked protein, CD55/ 
decay-accelerating factor (DAF), the clustering of which acti-
vates Abl kinase and drives Rac-dependent actin reorganization 
that in turn leads to translocation of virus particles to tight junc-
tions where they engage CAR and undergo endocytosis (Coyne 
and Bergelson, 2006). Binding to CD55 also activates the non-
receptor tyrosine kinase Fyn, which phosphorylates caveolin, 
thus facilitating endocytosis (Coyne and Bergelson, 2006). As 
CD55 cannot link directly to the actin cytoskeleton, it is unclear 
how actin-dependent translocation of virus–receptor complexes 
occurs, nor is it clear how the virus transits tight junctions and 
undergoes endocytosis. Nevertheless, this system provides an 
Figure 2.  Virus receptors. Virus entry is initiated by specific interactions between virus particles and receptors. (A) Human rhinovirus 2 undergoes receptor-
mediated endocytosis after interaction with LDLR. (B) CD4 is the primary receptor for HIVs, but virus penetration requires further interactions with chemo-
kine receptor CCR5 or CXCR4. Initial observations indicated that coreceptor engagement triggered fusion directly at the plasma membrane; however, 
recent studies suggest that fusion can also occur after endocytosis (Miyauchi et al., 2009). Although these mechanisms appear mutually exclusive, it is 
possible that both may operate, and additional studies are required to establish the relevant pathway for key target cells in vivo. (C) HCV entry requires 
at least four host factors. The virus particle is thought to directly interact with SR-B1 and CD81, whereas the tight junction components claudin-1 and 
occludin are indirectly involved. Data suggest that CD81/claudin-1 heteromers are necessary for infection. It is currently unknown how HCV is directed 
to clathrin-coated vesicles.1075 Receptor-mediated virus entry • Grove and Marsh
et al., 2003). Clathrin-mediated endocytosis is also required for 
DC-SIGN–mediated uptake of phleboviruses, with endocytic 
sorting signals in the N-terminal cytoplasmic domain of DC-
SIGN being essential for endocytosis and infection (Lozach   
et al., 2011b).
Although  highly  effective  in  many  cases,  the  strat-
egy of passive receptor-mediated uptake may limit the rate 
of entry, leaving a virus particle exposed on the cell surface. 
Thus, some viruses have developed the means to trigger their   
uptake into endocytic vesicles. Influenza A virus, for example, 
is  internalized  by  both  clathrin-mediated  endocytosis  and   
clathrin/caveolin-independent mechanisms (Rust et al., 2004). 
mimic  normal  tissues  can  provide  new  insights  to  infection 
mechanisms. Significantly, both coxsackievirus B and adeno-
virus type 2 entry require the activation of specific kinases that 
are potential targets for pharmacological intervention.
Receptor-mediated endocytosis
Receptor  engagement  initiates  events  that  enable  viruses  to 
transit the barrier imposed by the plasma membrane and associ-
ated structures. In most cells, the cortex (an elaborate network 
of actin fibers, actin-binding proteins, membrane-linker pro-
teins [e.g., ERM proteins], motor proteins, and other compo-
nents  tens  of  nanometers  thick)  supports  and  modulates  the 
physical and dynamic properties of the plasma membrane (Taylor 
et al., 2011). From the virus perspective, little attention has been 
paid to the actin cortex, in part because of the paucity of tools to 
study the structure but also because of the extent to which the 
cortex varies in different cell types, particularly in tissue culture 
lines. The cortex has the potential to prevent or delay the transit 
of large molecular assemblies from the cytoplasm toward the 
plasma membrane—for example, it excludes ribosomes from 
regions adjacent to the plasma membrane—and presumably sim-
ilarly restricts incoming virus particles (Marsh and Bron, 1997). 
In the few examples in which it has been studied, virus-induced 
receptor-mediated signaling can cause local actin perturbation 
to allow viruses that undergo penetration at the cell surface to 
transit the cortex (Fig. 1 B; Wang et al., 2005; Yoder et al., 
2008; Taylor et al., 2011). For HIV, Env engagement with the 
coreceptor CXCR4 on resting CD4
+ve T cells leads to Gi sig-
naling and subsequent activation of the actin-depolymerizing 
protein cofilin to induce local cortex reorganization that facili-
tates infection (Yoder et al., 2008). Cross-linking EGFR and 
v3 integrin by human cytomegalovirus at the cell surface re-
sults in the cooperative activation of phosphoinositide 3-kinase 
(PI3K) and Src, culminating in actin reorganization through 
RhoA and cofilin, events that correlate with translocation of 
human cytomegalovirus capsids to the nucleus and infection 
(Wang et al., 2005).
Endocytosis provides a mechanism through which viruses 
can pass through the cortex by exploiting intrinsic properties of 
endocytic vesicles to migrate (Fig. 1 A). The requirement for 
exposure to low pH, lysosomal enzymes, or even the reducing 
environment of the ER (see below) by many viruses ensures 
that they are captured by endocytic vesicles before undergoing   
the fusion/penetration reactions that allow them to transit the 
membrane  barrier  (Fig.  3).  Recent  system-based  approaches 
have identified several endocytic mechanisms, either constitu-
tively active or induced, that viruses can exploit (Mercer et al., 
2010b). One obvious feature of this endocytic involvement 
is that virus size tends to influence the mechanism of uptake. 
Thus, small viruses (approximately <140 nm in diameter) tend 
to use small endocytic vesicles. The best characterized of these 
is the clathrin-mediated pathway that is essential for produc-
tive infection by many viruses. Initially demonstrated for the 
alphavirus Semliki Forest virus (Helenius et al., 1980; Marsh 
and Helenius, 1980), a more recent study shows, for example, 
that  human  rhinovirus  2  is  internalized  via  the  constitutive 
clathrin-mediated  endocytosis  of  its  receptor  LDLR  (Snyers   
Figure 3.  Sites of virus particle fusion/penetration. Virus particles must 
transport genetic material across limiting membranes; this can be achieved 
at various locations within the cell. (A) Enveloped virus particles can fuse 
directly at the plasma membrane at neutral pH after interaction with cell 
surface receptors. (B and C) Alternatively, internalized virus particles can 
escape from the endosomal network. This is often dependent on endosome 
acidification and occurs at either mild pH (6.5–6) from the early endosome 
(B) or low pH (5.5–4) from late endosome and/or lysosome (C). In addi-
tion to the acidic environment, other molecular cues may be required to 
trigger fusion/penetration, for example, membrane lipid content (Semliki 
Forest virus and Dengue virus) or proteolytic cleavage (reovirus and SARS 
coronavirus;  Skehel  et  al.,  1982;  Schlegel  and  Wade,  1984;  Mothes 
et  al.,  2000;  Brabec  et  al.,  2003).  (D)  Polyomaviruses  such  as  SV40   
undergo  atypical  transport  through  the  endosomal  pathway  to  the  ER, 
where partially disassembled virus particles are shuttled to the cytosol by 
the retrotranslocation machinery.JCB • VOLUME 195 • NUMBER 7 • 2011   1076
Mimiviruses are the largest known viruses. With fibrils extending 
out to a diameter of 750 nm from an icosohedral capsid, these 
viruses are similar in size to small bacteria. Although typically 
found in amoebal hosts, in vitro mimivirus can infect profes-
sional phagocytes, such as macrophages, via PI3K and dynamin-II– 
dependent phagocytosis (Ghigo et al., 2008).
In contrast, macropinocytosis, which usually mediates the 
uptake of large volumes of extracellular fluid and bulky cargo 
such as apoptotic bodies (Mercer and Helenius, 2008; Mercer 
et al., 2010b), involves actin remodeling mediated by Rac-1 
GTPase and its effector p21-activated kinase 1 (Pak-1), lead-
ing to the extension of membrane ruffles and blebs from the 
cell surface. These large membrane protrusions can fold/drop 
back on themselves, enclosing extracellular material (Swanson, 
2008).  Macropinocytosis  can  occur  constitutively  in  profes-
sional phagocytes such as dendritic cells but can be induced in 
other cell types by activation of tyrosine kinases such as EGFR 
(Swanson, 2008). Kaposi’s sarcoma-associated herpesvirus,   
adenovirus (2 and 3), echovirus 1, Ebola virus, and Vaccinia,   
the prototype poxvirus, are internalized via macropinocytosis   
(Amstutz et al., 2008; Liberali et al., 2008; Mercer and Helenius,   
2008; Raghu et al., 2009; Mercer et al., 2010a; Nanbo et al., 
2010; Saeed et al., 2010; Valiya Veettil et al., 2010; Schmidt 
et al., 2011). Poxviruses have the unusual characteristic of 
producing two forms of infectious particle. Mature virions are 
brick-shaped particles that form in the cytoplasm of infected 
cells and possess a single-bilayer membrane. These particles are 
released when infected cells lyse. A second form, the so-called 
extracellular virus, is a mature virion that undergoes further   
envelopment by wrapping in membrane cisternae derived from 
the TGN or endosomes. These particles are secreted before cell 
lysis and have two membranes (Roberts and Smith, 2008). Dur-
ing entry, mature virus particles attach to preexisting filopodia 
and migrate toward the cell body, where they induce strain- 
specific atypical macropinocytosis via membrane blebbing or filo-
podial extension (Mercer et al., 2010a). The cellular receptors 
for Vaccinia virus are unknown, and it remains unclear how 
these processes are initiated. However, attachment of mature 
virions activates EGFR, Rho-GTPases, and actin remodeling 
(Mercer and Helenius, 2008; Mercer et al., 2010a). Phospha-
tidylserine  associated  with  the  mature  virion  membrane  has 
been proposed to contribute to Vaccinia virus–induced macro-
pinocytosis in a process mimicking the uptake of apoptotic cells 
(Mercer and Helenius, 2008), though another study disputes this 
(Laliberte and Moss, 2009). Recent work suggests that entry of 
the extracellular virion also involves macropinocytosis, though 
phosphatidylserine is not involved, and entry is not affected by 
exogenous addition of the phosphatidylserine-binding protein 
annexin 5 (Schmidt et al., 2011).
The filamentous particles of Ebola virus have a diameter 
of only 80–100 nm but range from 1–2 µm in length. It is not 
surprising  that  these  viruses  also  induce  macropinocytosis 
through Rac-1/Pak-1–dependent membrane ruffling. Although 
the role of the putative Ebola virus receptor TIM-1 in macro-
pinocytosis is unclear, Ebola virus uptake is promoted by the 
receptor tyrosine kinase Axl. The virus particle is not thought to 
directly engage Axl; however, Gas-6, an Axl ligand, has been 
For clathrin-mediated endocytosis, at least, influenza A virus 
attachment to sialic acid moieties on membrane glycoproteins 
and ganglioside initiates de novo clathrin-coated pit formation 
under surface-bound virions in a process that appears to involve 
ubiquitin-dependent recruitment of the clathrin adaptor protein 
Epsin-1 (Rust et al., 2004; Chen and Zhuang, 2008). An indepen-
dent study has demonstrated that activation of PI3K, but not Akt, 
is required for influenza A virus entry, and inhibition of PI3K 
prevents virus uptake into endosomes (Ehrhardt et al., 2006). 
It is proposed that influenza A virus–mediated clustering of   
sialylated receptor tyrosine kinases, such as EGFR or c-Met, 
activates tyrosine kinase and PI3K signaling (Eierhoff et al., 
2010). However, it remains unclear whether this signal propa-
gation is linked to virus internalization by a clathrin-dependent 
or -independent route. Virus-induced receptor clustering also 
seems to be important for signaling-dependent DC-SIGN– 
mediated infection of phleboviruses (Lozach et al., 2011b).
Other endocytic mechanisms used by viruses have been 
identified (Mercer et al., 2010b). Less is known about the mo-
lecular mechanisms and receptors involved or whether these 
pathways are constitutively active or driven by receptor engage-
ment. One such example is the pathway used by the polyoma-
virus SV40. This nonenveloped virus measures only 40 nm in 
diameter and exhibits a penetration mechanism that is currently 
unique to some polyomaviruses. SV40 particles bind directly to 
the cell surface via the sialic acid moieties of GM1 ganglio-
sides, for which there are 360 binding sites on the virion surface 
(Stehle et al., 1994). Aggregation of GM1 by multivalent parti-
cles results in lipid phase separation and the induction of mem-
brane deformation (Ewers et al., 2010). These two properties 
drive SV40 particles into tightly fitting membrane tubules that 
extend into the cell interior. Membrane tubulation is dependent 
on the long acyl chains of GM1 but is independent of cellular 
energy (Ewers et al., 2010). Subsequent scission of these invag-
inations requires tyrosine kinase activity and actin rearrange-
ments (Pelkmans et al., 2002; Ewers et al., 2010; Römer et al., 
2010). It has been suggested that caveolae coat proteins and   
dynamin are also recruited (Pelkmans et al., 2001, 2002); how-
ever, other studies indicate that Cav-1 is not essential for SV40 
infection (Damm et al., 2005; Ewers et al., 2010). Interestingly, 
membrane deformation by SV40 has parallels with the endo-
cytosis of shiga and cholera toxins (Römer et al., 2007, 2010).   
Although there is no sequence homology, similar pentameric 
ganglioside binding sites on SV40 and the two toxins, in con-
junction with the rigid structure of the long-chained glycosphin-
golipids, appear to induce asymmetric compressive stress that 
promotes local membrane tubulation (Neu et al., 2010). Some 
related polyomaviruses also induce tubulation and may share a 
common route of internalization (Ewers et al., 2010).
Physically larger virus particles, including poxviruses,   
filoviruses, herpesviruses, and the recently described mimiviruses 
(La Scola et al., 2003), cannot be accommodated by small 
endocytic vesicles and instead induce the formation of larger 
structures such as phagosomes or macropinosomes. Phagocyto-
sis is receptor driven and involves the actin-dependent forma-
tion of vesicles, the membrane of which is closely apposed to 
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and lysosomes (involving decreasing luminal pH, increasing 
levels of active hydrolytic enzymes, and alteration in lipid com-
position)  correlates  with  movement  of  endocytic  organelles 
toward the nucleus by microtubule-mediated retrograde translo-
cation. The need for some viruses to be delivered to more peri-
nuclear environments may be particularly important in some 
cell targets in vivo where cell organization is more elaborate 
and key for cell function. Neurons are an extreme example in 
which viruses may be taken into the cell by endocytosis at a 
peripheral synapse such as a neuromuscular junction but require 
transport, in some cases many tens of centimeters to the cell 
body and nucleus. In such cases, viruses can exploit endosomal 
transport along axons and use the lower pH of late endosomes 
(approximately pH 5.0) or exposure to acid hydrolases to delay   
penetration until endosomal or lysosomal delivery to a peri-
nuclear location (Fig. 3 C; Lozach et al., 2011a).
Additional molecular cues for fusion/penetration may 
be provided by the lipid composition of endosomal mem-
branes. The fusion of tick-borne encephalitis virus requires 
cholesterol in the target membrane (Stiasny et al., 2003), and 
fusion of Semliki Forest virus is dependent on both choles-
terol and sphingolipids (Kielian and Helenius, 1984; Nieva 
et al., 1994), both of which are available in the plasma mem-
brane as well as endosomal membranes. Dengue virus tran-
sits through the early endosomes to fuse with late endocytic 
organelles (van der Schaar et al., 2008). In addition to low 
pH, Dengue virus fusion requires the target membrane to con-
tain anionic lipids such as lysobisphosphatidic acid, which 
is predominantly found within the lysosome (Brotherus and   
Renkonen, 1977; Zaitseva et al., 2010). Other viruses, includ-
ing SARS coronavirus and orthoreoviruses, also exhibit atypi-
cal pH-dependent entry; in these cases, proteolytic cleavage 
of  the  viral  envelope  or  surface  proteins  by  acid-dependent 
cellular proteases (cathepsins L and B) triggers the structural 
changes required for fusion (Figs. 3 C and 4; Ebert et al., 2002; 
Chandran et al., 2005; Simmons et al., 2005). Ebola virus GP1 
glycoprotein also undergoes cleavage by cathepsins to reveal a 
putative binding domain for the late endosomal/lysosomal cho-
lesterol transporter Niemann–Pick C1 (NPC1; Chandran et al., 
2005; Schornberg et al., 2006; Côté et al., 2011). Depletion of   
NPC1  from  target  cells  prevents  Ebola  virus  glycoprotein- 
dependent fusion, suggesting that NPC1 acts as a postendocytic 
intracellular receptor necessary for virus penetration (Carette 
et al., 2011). These and other recent findings have provided in-
creasing clarity on Ebola virus infection, suggesting a putative 
entry pathway for this infamous virus (Fig. 4).
However, fusion/penetration is not restricted to endo-
cytic organelles. After their internalization, several polyoma-
viruses take an intracellular retrograde vesicular pathway to 
the ER via endosomes before penetration (Kartenbeck et al., 
1989). In the ER, these particles undergo partial uncoating 
mediated by protein-folding factors, including ERp57 and 
protein  disulfide  isomerase,  and  retrotranslocation  to  the   
cytosol by the machinery that normally mediates retrograde 
transport of misfolded ER proteins for cytosolic degradation 
(Fig. 3 D; Lilley et al., 2006; Schelhaas et al., 2007; Jiang   
et al., 2009).
shown to play a role in the entry of other viruses and may asso-
ciate with Ebola virus particles to act as a bridge for indirect   
interaction  with  Axl  (Shimojima  et  al.,  2006;  Nanbo  et  al., 
2010; Saeed et al., 2010; Brindley et al., 2011; Hunt et al., 
2011; Kondratowicz et al., 2011; Morizono et al., 2011).
Although  it  is  clear  that  many  viruses—in  particular, 
pH-dependent viruses—have an absolute dependence on endo-
cytosis for productive infection, some viruses may exhibit plas-
ticity in their mechanism of entry. For example, a study has 
demonstrated entry by direct fusion at the cell surface as well 
as by fusion after endocytosis for herpesviruses (Heldwein and 
Krummenacher, 2008). For HIV, pH-independent fusion, the 
ability of infected cells to form syncytia, and images of puta-
tive fusion events at the cell surface have led to the idea that 
entry occurs by direct fusion at the plasma membrane (Stein   
et al., 1987). However, work with inhibitors of endocytosis and 
direct single-particle tracking have recently provided evidence 
that fusion and infection occur after endocytic uptake (Daecke 
et al., 2005; Miyauchi et al., 2009; von Kleist et al., 2011). 
Moreover, HIV infection of macrophages has been suggested 
to require an atypical form of macropinocytosis (Maréchal et al., 
2001; Carter et al., 2011). Thus, factors that influence the kinet-
ics of fusion and internalization, such as receptor density and 
mobility, may determine whether pH-independent viruses pen-
etrate directly at the cell surface or after endocytosis. The abil-
ity to use different mechanisms may have distinct advantages 
for viruses, providing access to a broader range of cell types or 
rendering them less susceptible to situations in which a specific 
pathway is absent or blocked.
The great escape
As with virtually all endocytic cargoes, regardless of the mech-
anism of uptake, most viruses internalized by endocytosis are 
delivered to endosomes. Many of these will use endosomal 
environmental cues, usually low pH, to trigger the membrane   
fusion/penetration reactions that deliver the viral genetic mate-
rial to the cytoplasm (Fig. 3; details of the fusion and penetration 
mechanisms used by different viruses will not be considered 
here;  Kielian  and  Rey,  2006;  Moyer  and  Nemerow,  2011).   
Fusion or penetration from endosomes offers several potential 
advantages to a virus: it ensures that there is no cortical actin 
barrier to contend with, limits the display of viral components 
on the surface of the cell where they may be targets for the 
immune system, and, in the case of viruses that cause mem-
brane lysis, such as adenoviruses, limits membrane damage to 
a single endosome.
For an invading virus, the endosomal lumen is a dynamic 
labyrinth of vesicles and tubules. The sorting function of the 
early and recycling endosomes can potentially return virus– 
receptor complexes to the cell surface. Alternatively, matura-
tion to late endosomes and lysosomes renders the endosomal   
lumen a potentially hazardous environment (Dikic, 2006). Thus, 
many viruses fuse/penetrate at mildly acid pH (approximately 
pH 6.0) in early endosomes to avoid these fates (Fig. 3 B), 
whereas others exploit the changing environment within endo-
somes to precisely regulate the timing or cellular location of   
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so-called  actin  comets  to  propel  virus  particles  during  viral 
egress is well documented for Vaccinia virus (Taylor et al., 
2011). However, the intracellular transport strategy of insect 
baculoviruses is unique in their capacity to induce comet forma-
tion during entry. Upon reaching the cytoplasm, the baculovirus 
Autographa californica P78/83 capsid protein acts as a nucle-
ation site for Arp2/3-dependent actin polymerization that drives 
the virion through the cell interior. As capsids reach the nucleus, 
they are held against the nuclear membrane by continuing actin 
polymerization, promoting their ultimate invasion through nu-
clear pores (Ohkawa et al., 2010).
Conclusions
Cells raise multiple barriers to prevent virus infection. These are 
either general physical barriers, such as the plasma membrane or 
actin cortex, that define the cell or other restriction factors, often 
induced by interferons, that can be mobilized to limit viral repli-
cation. Although most viruses use broadly similar tactics to 
breach these barriers, many have developed unique approaches 
that ensure their delivery to optimal cellular sites for replication. 
The details of these specific mechanisms are starting to emerge. 
New technologies—in particular, in imaging—will provide key 
mechanistic insights into how virus receptors are organized, how 
they are commandeered by viruses to form functional entry com-
plexes, and how they engage the machinery of the cell to mediate 
infection. Such information will be essential in the development 
of targeted and specific inhibitors of virus entry and infection.
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